Zydus Lifesciences gets FDA final approval for BP drug generic version
Zydus Lifesciences (previously Cadila Healthcare) has secured final approval for Bisoprolol Fumarate and Hydrochlorothiazide tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, 10 mg/6.25 mg from the US Food and Drug Administration (FDA). Bisoprolol Fumarate and Hydrochlorothiazide tablets is a generic version of Ziac tablets. The combination of Bisoprolol Fumarate and hydrochlorothiazide has approval for […]